Treatment for Adenomyosis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Adenomyosis
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial will look at the effects of a common treatment for adenomyosis (radiofrequency ablation) by studying tissue that has been removed during a planned hysterectomy.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Day of intervention within 4 hours of RF (radiofrequency) treatment and 2 hours of completion of hysterectomy

Hour 4
Post-operative evidence of adenomyoma tissue ablation as assessed by pathological analysis

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

20 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: day of intervention within 4 hours of rf (radiofrequency) treatment and 2 hours of completion of hysterectomy

Who is running the clinical trial?

Hologic, Inc.Industry Sponsor
45 Previous Clinical Trials
57,830 Total Patients Enrolled
University of Texas Southwestern Medical CenterLead Sponsor
953 Previous Clinical Trials
608,817 Total Patients Enrolled
2 Trials studying Adenomyosis
100 Patients Enrolled for Adenomyosis
Kimberly Kho, MDPrincipal InvestigatorUT Southwestern Medical Center
1 Previous Clinical Trials
74 Total Patients Enrolled

Eligibility Criteria

Age 18+ · Female Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are considered to be a suitable candidate for surgery.